Citigroup’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $217K | Sell |
11,670
-23,150
| -66% | -$431K | ﹤0.01% | 3306 |
|
2025
Q1 | $632K | Buy |
34,820
+4,278
| +14% | +$77.6K | ﹤0.01% | 2823 |
|
2024
Q4 | $666K | Buy |
30,542
+13,148
| +76% | +$287K | ﹤0.01% | 2839 |
|
2024
Q3 | $476K | Buy |
17,394
+11,309
| +186% | +$310K | ﹤0.01% | 3020 |
|
2024
Q2 | $157K | Sell |
6,085
-16,651
| -73% | -$431K | ﹤0.01% | 3286 |
|
2024
Q1 | $682K | Buy |
22,736
+5,329
| +31% | +$160K | ﹤0.01% | 2639 |
|
2023
Q4 | $181K | Buy |
17,407
+13,539
| +350% | +$141K | ﹤0.01% | 3217 |
|
2023
Q3 | $52.9K | Buy |
+3,868
| New | +$52.9K | ﹤0.01% | 3427 |
|
2023
Q1 | – | Sell |
-46
| Closed | -$291 | – | 4788 |
|
2022
Q4 | $291 | Buy |
46
+2
| +5% | +$13 | ﹤0.01% | 4764 |
|
2022
Q3 | $1K | Sell |
44
-30
| -41% | -$682 | ﹤0.01% | 4791 |
|
2022
Q2 | $1K | Sell |
74
-74
| -50% | -$1K | ﹤0.01% | 5197 |
|
2022
Q1 | $7K | Sell |
148
-439
| -75% | -$20.8K | ﹤0.01% | 4881 |
|
2021
Q4 | $42K | Buy |
587
+186
| +46% | +$13.3K | ﹤0.01% | 4378 |
|
2021
Q3 | $47K | Buy |
401
+91
| +29% | +$10.7K | ﹤0.01% | 4017 |
|
2021
Q2 | $48K | Buy |
310
+89
| +40% | +$13.8K | ﹤0.01% | 4172 |
|
2021
Q1 | $42K | Sell |
221
-193
| -47% | -$36.7K | ﹤0.01% | 4131 |
|
2020
Q4 | $52K | Buy |
414
+97
| +31% | +$12.2K | ﹤0.01% | 4076 |
|
2020
Q3 | $34K | Buy |
317
+23
| +8% | +$2.47K | ﹤0.01% | 3682 |
|
2020
Q2 | $35K | Sell |
294
-282
| -49% | -$33.6K | ﹤0.01% | 3927 |
|
2020
Q1 | $58K | Buy |
576
+146
| +34% | +$14.7K | ﹤0.01% | 3675 |
|
2019
Q4 | $104K | Buy |
430
+307
| +250% | +$74.3K | ﹤0.01% | 3521 |
|
2019
Q3 | $20K | Sell |
123
-274
| -69% | -$44.6K | ﹤0.01% | 4274 |
|
2019
Q2 | $94K | Buy |
397
+127
| +47% | +$30.1K | ﹤0.01% | 3676 |
|
2019
Q1 | $71K | Buy |
270
+243
| +900% | +$63.9K | ﹤0.01% | 3797 |
|
2018
Q4 | $2K | Sell |
27
-44
| -62% | -$3.26K | ﹤0.01% | 4877 |
|
2018
Q3 | $14K | Buy |
+71
| New | +$14K | ﹤0.01% | 4630 |
|